Day: July 13, 2020

ANDOVER, Mass., July 13, 2020 (GLOBE NEWSWIRE) — MKS Instruments, Inc. (NASDAQ: MKSI), a global provider of technologies that enable advanced processes and improve productivity, today announced that the Company will release second quarter 2020 financial results after market close on Wednesday, July 29, 2020. A conference call with management will be held on Thursday, July 30, 2020 at 8:30 a.m. (Eastern Time). To participate in the conference call, please dial (877) 212-6076 for domestic callers and (707) 287-9331 for international callers, and an operator will connect you.  Participants will need to provide the operator with the Conference ID of 1428938, which has been reserved for this call. Participants are asked to dial in at least 15 minutes in advance to ensure a timely connection to the call.  A live and archived webcast of...

New York, July 13, 2020 (GLOBE NEWSWIRE) — Grayscale Investments, the largest digital currency asset manager, today announced that its Chief Executive Officer and Founder, Barry Silbert, will be featured on an investor call on Thursday, July 16, 2020 at 1:00 PM Eastern Daylight Time. Marissa Arnold press@grayscale.co

CALGARY, Alberta, July 13, 2020 (GLOBE NEWSWIRE) — Eguana Technologies Inc. (the “Company”) (TSX-V:EGT) (OTCQB:EGTYF), announced today that the board of directors has granted incentive stock options to acquire up to an aggregate of 2,305,000 common shares at a strike price of $0.15 per share. Of the options granted, 1,175,000 have been granted to directors and officers of the Company and the remainder to employees.The incentive stock options represent the 2020 annual grant. The options vest in three equal tranches with the first tranche to vest immediately and the remainder over two years with an expiry of July 15, 2030. The grant of the options is subject to the terms of the Stock Option Plan and the approval of the TSX Venture Exchange.About Eguana Technologies Inc.Based in Calgary, Alberta Canada, Eguana Technologies Inc. (EGT:...

SAN DIEGO, July 13, 2020 (GLOBE NEWSWIRE) — Turning Point Therapeutics, Inc. (NASDAQ: TPTX), a precision oncology company developing next-generation therapies that target genetic drivers of cancer, today announced the appointment of Andrew Partridge as executive vice president and chief commercial officer, effective today. Mr. Partridge has more than 20 years of global pharmaceutical sales and marketing experience leading more than 20 commercial launches across multiple indications, including oncology, hematology and rare diseases.“As we progress our global registrational study of repotrectinib and with three other earlier stage drug candidates in our pipeline, I am pleased to have a commercial veteran of Andy’s caliber to lead our market planning and commercialization efforts,” said Dr. Athena Countouriotis, president and chief...

SAN MATEO, Calif., July 13, 2020 (GLOBE NEWSWIRE) — SurveyMonkey (Nasdaq: SVMK), a leading global survey software company, today announced it has been listed among Parity.org’s Best Companies for Women to Advance for 2020. This list recognizes organizations that have implemented a mix of exemplary benefits, policies, and programs that ensure women have significant opportunities to advance their careers.SurveyMonkey has long championed workplace diversity and inclusion. The organization’s board of directors and senior leadership team have equal numbers of women and men represented, and in 2019 the company announced long- and short-term goals to improve the representation of women and people of color among the employee population. SurveyMonkey seeks to achieve parity for women and men by 2024, while allowing room for gender...

SANTA CLARA, Calif., July 13, 2020 (GLOBE NEWSWIRE) — NVIDIA today announced that it has named to its board of directors John Dabiri, the Centennial Professor of aeronautics and mechanical engineering at the California Institute of Technology, where he previously served as dean of Students and chair of the Faculty Board.Dabiri, age 40, recently returned to Caltech after four years at Stanford University, where he was a professor of civil and environmental engineering and of mechanical engineering. He heads the Dabiri Lab, which conducts research at the intersections of fluid mechanics, energy and environment, and biology.“John is an outstanding addition to our board of directors,” said Jensen Huang, founder and CEO of NVIDIA. “He is an extraordinary researcher and leader. He will bring unique perspectives and insight to our work...

SANTA MONICA, Calif., July 13, 2020 (GLOBE NEWSWIRE) — Society6 today announced it saw its strongest July 4th sale in the brand’s history. The artist-driven online marketplace, featuring made-to-order products in home décor, wall art, apparel and accessories, saw more than 150% average daily Gross Transaction Value (GTV) growth1 compared to last year’s July 4th campaign.This year’s July 4th campaign generated over $5 million GTV with top selling products, including art prints, framed art prints and throw pillows. Face masks, launched in late June, continued to perform well throughout the holiday weekend. Society6 continues to focus on mobile optimization, including recent improvements to mobile checkout, which helped drive improved conversion during the holiday sale.“Our revamped merchandising strategy and new mobile optimizations...

ARQ-252 is a potent and highly selective topical JAK1 inhibitor offering potential safety advantages over less selective JAK inhibitorsCompany expects topline data in the second half of 2021WESTLAKE VILLAGE, Calif., July 13, 2020 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (Nasdaq: ARQT), a medical dermatology company developing innovative treatments for patients with immune-mediated dermatological diseases and conditions, today announced that it initiated enrollment in the Phase 2b portion of the Phase 1/2b study of ARQ-252, a potent and highly selective topical small molecule inhibitor of Janus kinase type 1 (JAK1), in adult patients with chronic hand eczema. Topline data from this trial are expected in the second half of 2021.“More than eight million people in the U.S. suffer from hand eczema, a chronic skin disease that...

SAN JOSE, Calif., July 13, 2020 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (“AnPac Bio,” the “Company” or “we”) (NASDAQ: ANPC), a biotechnology company with operations in China and the United States focused on early cancer screening and detection, pre-announced certain results from the quarter ending 6/30/20. The Company performed 6,500 paid tests in June 2020, which was almost 50% higher than the average monthly paid tests in 2019.  Based on unaudited numbers for the first half of the year in 2020 through 6/30/20, revenue was slightly higher compared to the same period in 2019, while the average selling price (ASP) increased as well over 2019.  AnPac Bio plans to file the 1st half year results on August 28, 2020.  Highlights during the period of the 1st half of 2020:The Company successfully listed on the NASDAQ stock...